179 related articles for article (PubMed ID: 37473755)
1. GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism.
Sjøberg KA; Sigvardsen CM; Alvarado-Diaz A; Andersen NR; Larance M; Seeley RJ; Schjerling P; Knudsen JG; Katzilieris-Petras G; Clemmensen C; Jørgensen SB; De Bock K; Richter EA
Cell Metab; 2023 Aug; 35(8):1327-1340.e5. PubMed ID: 37473755
[TBL] [Abstract][Full Text] [Related]
2. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.
Emmerson PJ; Wang F; Du Y; Liu Q; Pickard RT; Gonciarz MD; Coskun T; Hamang MJ; Sindelar DK; Ballman KK; Foltz LA; Muppidi A; Alsina-Fernandez J; Barnard GC; Tang JX; Liu X; Mao X; Siegel R; Sloan JH; Mitchell PJ; Zhang BB; Gimeno RE; Shan B; Wu X
Nat Med; 2017 Oct; 23(10):1215-1219. PubMed ID: 28846098
[TBL] [Abstract][Full Text] [Related]
3. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates.
Mullican SE; Lin-Schmidt X; Chin CN; Chavez JA; Furman JL; Armstrong AA; Beck SC; South VJ; Dinh TQ; Cash-Mason TD; Cavanaugh CR; Nelson S; Huang C; Hunter MJ; Rangwala SM
Nat Med; 2017 Oct; 23(10):1150-1157. PubMed ID: 28846097
[TBL] [Abstract][Full Text] [Related]
4. GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS.
Tsai VW; Zhang HP; Manandhar R; Schofield P; Christ D; Lee-Ng KKM; Lebhar H; Marquis CP; Husaini Y; Brown DA; Breit SN
Int J Obes (Lond); 2019 Dec; 43(12):2370-2380. PubMed ID: 31152154
[TBL] [Abstract][Full Text] [Related]
5. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.
Yang L; Chang CC; Sun Z; Madsen D; Zhu H; Padkjær SB; Wu X; Huang T; Hultman K; Paulsen SJ; Wang J; Bugge A; Frantzen JB; Nørgaard P; Jeppesen JF; Yang Z; Secher A; Chen H; Li X; John LM; Shan B; He Z; Gao X; Su J; Hansen KT; Yang W; Jørgensen SB
Nat Med; 2017 Oct; 23(10):1158-1166. PubMed ID: 28846099
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats.
Liu X; Pérusse F; Bukowiecki LJ
Am J Physiol; 1998 May; 274(5):R1212-9. PubMed ID: 9644032
[TBL] [Abstract][Full Text] [Related]
7. GDF15 promotes weight loss by enhancing energy expenditure in muscle.
Wang D; Townsend LK; DesOrmeaux GJ; Frangos SM; Batchuluun B; Dumont L; Kuhre RE; Ahmadi E; Hu S; Rebalka IA; Gautam J; Jabile MJT; Pileggi CA; Rehal S; Desjardins EM; Tsakiridis EE; Lally JSV; Juracic ES; Tupling AR; Gerstein HC; Paré G; Tsakiridis T; Harper ME; Hawke TJ; Speakman JR; Blondin DP; Holloway GP; Jørgensen SB; Steinberg GR
Nature; 2023 Jul; 619(7968):143-150. PubMed ID: 37380764
[TBL] [Abstract][Full Text] [Related]
8. GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.
Frikke-Schmidt H; Hultman K; Galaske JW; Jørgensen SB; Myers MG; Seeley RJ
Mol Metab; 2019 Mar; 21():13-21. PubMed ID: 30685336
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice.
Suriben R; Chen M; Higbee J; Oeffinger J; Ventura R; Li B; Mondal K; Gao Z; Ayupova D; Taskar P; Li D; Starck SR; Chen HH; McEntee M; Katewa SD; Phung V; Wang M; Kekatpure A; Lakshminarasimhan D; White A; Olland A; Haldankar R; Solloway MJ; Hsu JY; Wang Y; Tang J; Lindhout DA; Allan BB
Nat Med; 2020 Aug; 26(8):1264-1270. PubMed ID: 32661391
[TBL] [Abstract][Full Text] [Related]
10. Prolonged β
van Beek SMM; Kalinovich A; Schaart G; Bengtsson T; Hoeks J
Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E619-E628. PubMed ID: 33522400
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies.
Haluzik M; Gavrilova O; LeRoith D
Endocrinology; 2004 Apr; 145(4):1662-7. PubMed ID: 14670996
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice.
Bajzer M; Olivieri M; Haas MK; Pfluger PT; Magrisso IJ; Foster MT; Tschöp MH; Krawczewski-Carhuatanta KA; Cota D; Obici S
Diabetologia; 2011 Dec; 54(12):3121-31. PubMed ID: 21987346
[TBL] [Abstract][Full Text] [Related]
13. The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance.
Klein AB; Nicolaisen TS; Johann K; Fritzen AM; Mathiesen CV; Gil C; Pilmark NS; Karstoft K; Blond MB; Quist JS; Seeley RJ; Færch K; Lund J; Kleinert M; Clemmensen C
Cell Rep; 2022 Aug; 40(8):111258. PubMed ID: 36001956
[TBL] [Abstract][Full Text] [Related]
14. Moderate SIRT1 overexpression protects against brown adipose tissue inflammation.
Escalona-Garrido C; Vázquez P; Mera P; Zagmutt S; García-Casarrubios E; Montero-Pedrazuela A; Rey-Stolle F; Guadaño-Ferraz A; Rupérez FJ; Serra D; Herrero L; Obregon MJ; Valverde ÁM
Mol Metab; 2020 Dec; 42():101097. PubMed ID: 33049408
[TBL] [Abstract][Full Text] [Related]
15. Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure.
Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Nadwa EH; Albogami SM; Alorabi M; Saad HM; Batiha GE
J Diabetes; 2022 Dec; 14(12):806-814. PubMed ID: 36444166
[TBL] [Abstract][Full Text] [Related]
16. Weight Loss Induced by Bariatric Surgery Restricts Hepatic
Adolph TE; Grabherr F; Mayr L; Grander C; Enrich B; Moschen AR; Tilg H
J Obes; 2018; 2018():7108075. PubMed ID: 30533221
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of beta3-adrenoceptors in gut and adipose tissue of genetically obese (ob/ob) C57BL/6J-mice.
Evans BA; Papaioannou M; Anastasopoulos F; Summers RJ
Br J Pharmacol; 1998 Jun; 124(4):763-71. PubMed ID: 9690869
[TBL] [Abstract][Full Text] [Related]
18. Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis.
Guo X; Asthana P; Zhai L; Cheng KW; Gurung S; Huang J; Wu J; Zhang Y; Mahato AK; Saarma M; Ustav M; Kwan HY; Lyu A; Chan KM; Xu P; Bian ZX; Wong HLX
Nat Commun; 2024 Feb; 15(1):1034. PubMed ID: 38310105
[TBL] [Abstract][Full Text] [Related]
19. Dietary medium-chain fatty acids reduce food intake via the GDF15-GFRAL axis in mice.
Kanta JM; Deisen L; Johann K; Holm S; Lundsgaard A; Lund J; Jähnert M; Schürmann A; Clemmensen C; Kiens B; Fritzen AM; Kleinert M
Mol Metab; 2023 Aug; 74():101760. PubMed ID: 37356805
[TBL] [Abstract][Full Text] [Related]
20. Camptothecin effectively treats obesity in mice through GDF15 induction.
Lu JF; Zhu MQ; Xie BC; Shi XC; Liu H; Zhang RX; Xia B; Wu JW
PLoS Biol; 2022 Feb; 20(2):e3001517. PubMed ID: 35202387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
